Search research articles
Contact Us
Filters
Showing results (111-120 of 200) with videos related to
Page
of 20
Sort By:
Journal of Managed Care & Specialty Pharmacy
|
March 23, 2016
Health Care Utilization and Costs After Initiating Budesonide/Formoterol Combination or Fluticasone/Salmeterol Combination Among COPD Patients New to ICS/LABA Treatment
Jill R Davis, David M Kern, Setareh A Williams, et al.
Journal of Behavioral Medicine
|
May 7, 2013
The impact of age on outcomes in chronic obstructive pulmonary disease differs by relationship status
Kristen E Holm, Melissa R Plaufcan, Dee W Ford, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|
May 9, 2024
Validation of the Onset of Effect Questionnaire in Participants With Chronic Obstructive Pulmonary Disease
Charlie Strange, Barry J Make, Frank J Trudo, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
October 10, 2015
Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments
Frank Trudo, David M Kern, Jill R Davis, et al.
COPD
|
July 19, 2013
Safety and pharmacokinetics of 120 mg/kg versus 60 mg/kg weekly intravenous infusions of alpha-1 proteinase inhibitor in alpha-1 antitrypsin deficiency: a multicenter, randomized, double-blind, crossover study (SPARK)
Michael A Campos, Friedrich Kueppers, James M Stocks, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|
December 5, 2024
Improving the Likelihood of Identifying Alpha-1 Antitrypsin Deficiency Among Patients With COPD: A Novel Predictive Model Using Real-World Data
Daniel N Pfeffer, Rahul Dhakne, Omnya El Massad, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
December 10, 2021
Feasibility of RESP-FIT: Technology-Enhanced Self-Management Intervention for Adults with COPD
Sarah Miller, Ronald Teufel, Michelle Nichols, et al.
International Journal of Behavioral Medicine
|
July 11, 2014
The social environment and illness uncertainty in chronic obstructive pulmonary disease
Karin F Hoth, Frederick S Wamboldt, Dee W Ford, et al.
Journal of Managed Care & Specialty Pharmacy
|
November 25, 2022
Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS study
Kristin A Evans, Michael Pollack, Edward Portillo, et al.
Genetic Testing
|
December 17, 2008
Barriers to genetic testing among persons at risk for alpha-1 antitrypsin deficiency
Marguerite R Dickson, Cindy L Carter, Matthew J Carpenter, et al.
Page
of 20
Search research articles
Search
Showing results (111-120 of 200) with videos related to
Sort By:
Page
of 20
Journal of Managed Care & Specialty Pharmacy
|
March 23, 2016
Health Care Utilization and Costs After Initiating Budesonide/Formoterol Combination or Fluticasone/Salmeterol Combination Among COPD Patients New to ICS/LABA Treatment
Jill R Davis, David M Kern, Setareh A Williams, et al.
Journal of Behavioral Medicine
|
May 7, 2013
The impact of age on outcomes in chronic obstructive pulmonary disease differs by relationship status
Kristen E Holm, Melissa R Plaufcan, Dee W Ford, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|
May 9, 2024
Validation of the Onset of Effect Questionnaire in Participants With Chronic Obstructive Pulmonary Disease
Charlie Strange, Barry J Make, Frank J Trudo, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
October 10, 2015
Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments
Frank Trudo, David M Kern, Jill R Davis, et al.
COPD
|
July 19, 2013
Safety and pharmacokinetics of 120 mg/kg versus 60 mg/kg weekly intravenous infusions of alpha-1 proteinase inhibitor in alpha-1 antitrypsin deficiency: a multicenter, randomized, double-blind, crossover study (SPARK)
Michael A Campos, Friedrich Kueppers, James M Stocks, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|
December 5, 2024
Improving the Likelihood of Identifying Alpha-1 Antitrypsin Deficiency Among Patients With COPD: A Novel Predictive Model Using Real-World Data
Daniel N Pfeffer, Rahul Dhakne, Omnya El Massad, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
December 10, 2021
Feasibility of RESP-FIT: Technology-Enhanced Self-Management Intervention for Adults with COPD
Sarah Miller, Ronald Teufel, Michelle Nichols, et al.
International Journal of Behavioral Medicine
|
July 11, 2014
The social environment and illness uncertainty in chronic obstructive pulmonary disease
Karin F Hoth, Frederick S Wamboldt, Dee W Ford, et al.
Journal of Managed Care & Specialty Pharmacy
|
November 25, 2022
Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS study
Kristin A Evans, Michael Pollack, Edward Portillo, et al.
Genetic Testing
|
December 17, 2008
Barriers to genetic testing among persons at risk for alpha-1 antitrypsin deficiency
Marguerite R Dickson, Cindy L Carter, Matthew J Carpenter, et al.
Page
of 20